Experience: Chemical Engineering, Cancer Cell Biology & Gene Therapy 

Credentials: Excellence in Research Award, Northeastern University; Sigilon Therapeutics Collaboration and Innovation Award; MassChallenge Gold Winner 

Key Biotechnology: E Coli-derived human insulin. It doesn't feel like alternative biotechnology now. Still, when it was developed, the idea that human proteins could be grown in bacteria and mass-produced changed the world

Differentiators: I oversaw the manufacturing of a full clinical trial's drug doses.